Qube Research & Technologies (QRT)
SYRS

Qube Research & Technologies (QRT)’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-122,174
Closed -$28.1K – 3973
2024
Q4 		$28.1K Buy
122,174
+44,458
+57% +$53.4K ﹤0.01% 3155
2024
Q3 		$167K Buy
77,716
+49,557
+176% +$178K ﹤0.01% 2640
2024
Q2 		$145K Sell
28,159
-109,722
-80% -$577K ﹤0.01% 2517
2024
Q1 		$738K Buy
+137,881
New +$953K ﹤0.01% 2323
2022
Q3 		– Sell
-5,357
Closed -$52K – 3149
2022
Q2 		$52K Buy
+5,357
New +$50.1K ﹤0.01% 2119
2021
Q3 		– Sell
-7,877
Closed -$429K – 2888
2021
Q2 		$429K Buy
7,877
+4,228
+116% +$250K ﹤0.01% 1357
2021
Q1 		$273K Buy
+3,649
New +$379K ﹤0.01% 1507

Other funds holding SYRS

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $339M AUM 120.53% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SYRS Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 122,174 shares — an estimated $28.1K sold.

Qube Research & Technologies (QRT) first reported a position in SYRS in Q1 2021 and held it in 7 quarters. The position peaked at $738K in Q1 2024. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 122,174 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $28.1K.
  • Qube Research & Technologies (QRT) first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Syros Pharmaceuticals, Inc. Common Stock position peaked at $738K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.